Biogen (BIIB) PT Raised to $300 at Wedbush, After FDA Approves Aduhelm (Aducanumab)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. DGNX
4. RDDT
5. BRUN
6. ELUT
7. EMAT
8. CV
9. YSS
10. BBIO

Go back to Biogen (BIIB) PT Raised to $300 at Wedbush, After FDA Approves Aduhelm (Aducanumab)
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 210.65 --0 (-0%)
Previous Close $210.65    52 Week High $333.65 
Open $210.65    52 Week Low $223.02 
Day High $210.65    P/E 26.97 
Day Low $210.65    EPS $7.81 
Volume 29